Taken together, this show that the inflammatory serum protein signature of NASH can be linked to disease pathogenesis in the liver and that deregulation in hepatocytes (ST1A1) might occur before appearance of the broader NASH-specific inflammatory signature. Here, SULT1A1 is linked to metabolic dysfunction-associated steatohepatitis.